Filing Details
- Accession Number:
- 0001209191-23-014739
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-02 16:44:07
- Reporting Period:
- 2023-02-28
- Accepted Time:
- 2023-03-02 16:44:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1725057 | Ceridian Hcm Holding Inc. | CDAY | Services-Prepackaged Software (7372) | 463231686 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1809266 | Scott Jeffrey Jacobs | C/O Ceridian Hcm Holding Inc. 3311 E. Old Shakopee Road Minneapolis MN 55425 | Head Of Acct & Fin Reporting | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-28 | 8,227 | $0.00 | 18,755 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2023-03-01 | 24 | $72.86 | 18,731 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Units | Acquisiton | 2023-02-28 | 845 | $0.00 | 845 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 845 | 2033-02-28 | No | 4 | A | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | $17.58 | 2025-12-08 | 500 | 500 | Direct | |
| Common Stock | Option (right to buy) | $16.82 | 2026-12-31 | 1,125 | 1,125 | Direct | |
| Common Stock | Option (right to buy) | $19.04 | 2027-12-20 | 5,000 | 5,000 | Direct | |
| Common Stock | Option (right to buy) | $22.00 | 2028-04-25 | 32,610 | 32,610 | Direct | |
| Common Stock | Option (right to buy) | $44.91 | 2029-02-08 | 712 | 712 | Direct | |
| Common Stock | Option (right to buy) | $49.93 | 2029-03-20 | 8,396 | 8,396 | Direct | |
| Common Stock | Option (right to buy) | $65.26 | 2030-05-08 | 14,299 | 14,299 | Direct | |
| Common Stock | Performance Units | $0.00 | 2031-03-08 | 1,647 | 1,647 | Direct | |
| Common Stock | Performance Units | $0.00 | 2032-02-24 | 2,352 | 2,352 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2025-12-08 | 500 | 500 | Direct |
| 2026-12-31 | 1,125 | 1,125 | Direct |
| 2027-12-20 | 5,000 | 5,000 | Direct |
| 2028-04-25 | 32,610 | 32,610 | Direct |
| 2029-02-08 | 712 | 712 | Direct |
| 2029-03-20 | 8,396 | 8,396 | Direct |
| 2030-05-08 | 14,299 | 14,299 | Direct |
| 2031-03-08 | 1,647 | 1,647 | Direct |
| 2032-02-24 | 2,352 | 2,352 | Direct |
Footnotes
- 8,227 shares of common stock of the Issuer ("Common Stock") that are issuable pursuant to Restricted Stock Units ("RSUs"), granted on February 28, 2023, that vest in three annual installments beginning on February 28, 2024.
- 24 shares of Common Stock were sold to cover withholding taxes as required pursuant to the terms of the RSU award agreement and 50 shares of Common Stock were issued to the Reporting Person in connection with the vesting of 74 RSUs on February 28, 2023.
- Includes (i) 5,522 shares of Common Stock, (ii) shares of Common Stock issuable pursuant to RSUs, granted on May 8, 2020, of which 511 shares vest on May 8, 2023; (iii) shares of Common Stock that are issuable pursuant to RSUs, granted on March 8, 2021, of which 823 shares vest on March 8, 2023 and 824 shares that vest on March 8, 2024; (iv) shares of Common Stock issuable pursuant to RSUs, granted on February 24, 2022, of which 1,412 shares vest on each of February 24, 2024 and February 24, 2025; and (v) shares of Common Stock issuable pursuant to RSUs, granted on February 28, 2023, of which 2,742 shares vest on each of February 28, 2024 and February 28, 2025, and 2,743 shares vest on February 28, 2026.
- Fully vested and exercisable.
- Consists of 6,297 vested and exercisable options as of March 20, 2022, and 2,099 options that vest and become exercisable on March 20, 2023.
- Consists of 7,149 vested and exercisable options as of May 8, 2022, and 3,575 options that vest and become exercisable on each of May 8, 2023, and May 8, 2024.
- Given the Company's performance in 2021 and pursuant to the terms of the PSU award agreement, each PSU granted on March 8, 2021 converted into 1 share of Common Stock upon vesting. The vesting of 823 and 824 PSUs occurs on each of March 8, 2023 and March 8, 2024, respectively.
- Pursuant to the terms of the PSU award agreement, the vesting of 1,176 PSUs occurs on each of February 24, 2024 and February 24, 2025.
- Each PSU represents a contingent right to receive shares of Common Stock based upon the degree to which one or more of the performance metrics under the Company's 2023 Management Incentive Plan ("2023 MIP") are satisfied. The number of PSUs reported in columns 5, 7 and 9 of Table II reflects achievement at the target level of performance under the 2023 MIP. Based on actual results during the fiscal year ended December 31, 2023, the aggregate number of shares of Common Stock issued may range from zero shares to 167% of the target number of shares reported in columns 5, 7, and 9 of Table II. The PSUs will only vest upon the later of (i) the date the Compensation Committee or the Board of Directors of the Company certify that one or more of the performance metrics have been met under the 2023 MIP for the individual and (ii) the one-year anniversary of the date of grant.
Billionaire Hedge Funds
